Nuvectis Pharma
NVCT----
Nuvectis Pharma (NVCT)
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Nuvectis Pharma Analyst Rating
View MoreForecast & Rating
Jul 23, 2026Price forecast
$31.0057.28%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · 2 hours ago
Maxim Group Keeps Their Buy Rating on Nuvectis Pharma (NVCT)
- Tip Ranks · 1 day ago, 10:25 AM
Pantginis Reiterates Buy on Nuvectis, Citing Ciprocopan Approval and Pipeline Diversification; Price Target Maintained at $39
- Unusual Whales · 1 day ago, 06:33 AM
Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors
- PUBT · 1 day ago, 06:32 AM
Nuvectis says China regulator approves ciprocopan for treatment-naive PNH patients
- Yicai · 1 day ago, 06:27 AM
China's Haisco Gets China’s Nod for Rare Blood Disorder Drug
- businessinsider · Jul 9 at 06:45 AM
The Billion-Dollar Pill: With NXP100, Nuvectis Pharma Just Staked Its Claim in the New Biotech Gold Rush
